51 – 60 of 140
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk : The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
(
- Contribution to journal › Article
-
Mark
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD-02 study design and first results
(
- Contribution to journal › Article
-
Mark
Eleven Amino Acids of HLA-DRB1 and Fifteen Amino Acids of HLA-DRB3, 4 and 5 Include Potentially "Causal Residues" Responsible for the Risk of Childhood Type 1 Diabetes
(
- Contribution to journal › Article
-
Mark
Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children
(
- Contribution to journal › Article
-
Mark
Metabolite-related dietary patterns and the development of islet autoimmunity
(
- Contribution to journal › Article
-
Mark
HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy
(
- Contribution to journal › Article
-
Mark
Who is enrolling? The path to monitoring in type 1 diabetes trialnet’s pathway to prevention
(
- Contribution to journal › Article
- 2018
-
Mark
Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children
(
- Contribution to journal › Article
-
Mark
Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident β-cell autoantibodies
(
- Contribution to journal › Article
-
Mark
Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes : A randomized clinical trial
(
- Contribution to journal › Article